Zhejiang Hisun Biomaterials Stock Fundamentals
| 688203 Stock | 10.49 0.21 2.04% |
Zhejiang HISUN Biomaterials fundamentals help investors to digest information that contributes to Zhejiang HISUN's financial success or failures. It also enables traders to predict the movement of Zhejiang Stock. The fundamental analysis module provides a way to measure Zhejiang HISUN's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zhejiang HISUN stock.
At present, Zhejiang HISUN's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 20.9 M, whereas Tax Provision is forecasted to decline to about 6.5 M. Zhejiang | Select Account or Indicator |
Zhejiang HISUN Biomaterials Company Current Valuation Analysis
Zhejiang HISUN's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Zhejiang HISUN Current Valuation | 1.76 B |
Most of Zhejiang HISUN's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhejiang HISUN Biomaterials is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Zhejiang HISUN Biomaterials has a Current Valuation of 1.76 B. This is 84.61% lower than that of the Chemicals sector and 87.37% lower than that of the Materials industry. The current valuation for all China stocks is 89.44% higher than that of the company.
Zhejiang HISUN Bioma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zhejiang HISUN's current stock value. Our valuation model uses many indicators to compare Zhejiang HISUN value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zhejiang HISUN competition to find correlations between indicators driving Zhejiang HISUN's intrinsic value. More Info.Zhejiang HISUN Biomaterials is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zhejiang HISUN Biomaterials is roughly 2.23 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Zhejiang HISUN by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zhejiang HISUN's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Zhejiang Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhejiang HISUN's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhejiang HISUN could also be used in its relative valuation, which is a method of valuing Zhejiang HISUN by comparing valuation metrics of similar companies.Zhejiang HISUN is currently under evaluation in current valuation category among its peers.
Zhejiang Fundamentals
| Return On Equity | 0.0267 | ||||
| Return On Asset | 0.012 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.76 B | ||||
| Shares Outstanding | 202.68 M | ||||
| Shares Owned By Insiders | 70.21 % | ||||
| Shares Owned By Institutions | 1.15 % | ||||
| Price To Book | 1.39 X | ||||
| Price To Sales | 2.46 X | ||||
| Revenue | 753.32 M | ||||
| Gross Profit | 80.89 M | ||||
| EBITDA | 100.72 M | ||||
| Net Income | 43.55 M | ||||
| Total Debt | 179.55 M | ||||
| Book Value Per Share | 7.39 X | ||||
| Cash Flow From Operations | 163.03 M | ||||
| Earnings Per Share | 0.20 X | ||||
| Number Of Employees | 383 | ||||
| Beta | 0.66 | ||||
| Market Capitalization | 2.13 B | ||||
| Total Asset | 2.05 B | ||||
| Retained Earnings | 65.57 M | ||||
| Working Capital | 627.83 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.05 B | ||||
| Last Dividend Paid | 0.08 |
About Zhejiang HISUN Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhejiang HISUN Biomaterials's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhejiang HISUN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhejiang HISUN Biomaterials based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 753.3 M | 606.8 M | |
| Cost Of Revenue | 654.5 M | 514.3 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Zhejiang Stock
Zhejiang HISUN financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang HISUN security.